Sumatriptan succinate and Turmeric drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sumatriptan succinate (sumatriptan succinate) and Turmeric (turmeric). Common drug interactions include corneal disorder among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Sumatriptan succinate and Turmeric. It is created by eHealthMe based on reports of 80 people who take the same drugs from the FDA, and is updated regularly.

What is Sumatriptan succinate?

Sumatriptan succinate has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 9,731 Sumatriptan succinate users. Check the latest studies of Sumatriptan succinate.

What is Turmeric?

Turmeric has active ingredients of turmeric. It is often used in inflammation. eHealthMe is studying from 16,563 Turmeric users. Check the latest studies of Turmeric.



On Jul, 11, 2026

80 people who take Sumatriptan succinate and Turmeric together, and have interactions are studied.

Sumatriptan succinate and Turmeric drug interactions.

What are the common drug interactions of Sumatriptan Succinate and Turmeric, by gender? *:

female:

  1. Corneal disorder
  2. Decreased appetite
  3. Drug ineffective
  4. Dysarthria (speech disorder)
  5. Dyspepsia (indigestion)
  6. Eye pain
  7. Sinusitis (inflammation of sinus)
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Oedema (fluid collection in tissue)

male:

  1. Fatigue (feeling of tiredness)
  2. Influenza like illness
  3. Headache (pain in head)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Insomnia (sleeplessness)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Peripheral swelling
  8. Pruritus (severe itching of the skin)
  9. Rib fracture
  10. Skin ulcer

What are the common drug interactions of Sumatriptan Succinate and Turmeric, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cough
  2. Dysarthria (speech disorder)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fatigue (feeling of tiredness)
  5. Infection
  6. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  7. Insomnia (sleeplessness)
  8. Nausea (feeling of having an urge to vomit)
  9. Alopecia (absence of hair from areas of the body)
  10. Aphonia (inability to produce voice)

40-49:

  1. Dizziness
  2. Fatigue (feeling of tiredness)
  3. Memory impairment
  4. Abdominal discomfort
  5. Anxiety
  6. Face injury
  7. Fall
  8. Ligament sprain (ligament stretched)
  9. Loss of consciousness
  10. Post-traumatic stress disorder

50-59:

  1. Chest discomfort
  2. Chest pain
  3. Crest syndrome (thick, dry and fibrous skin)
  4. Death
  5. Respiratory syncytial virus infection (viral disease of respiratory system)
  6. Retinal vein occlusion (a blockage of the small veins that carry blood away from the retina)
  7. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  8. Throat tightness
  9. Anaemia (lack of blood)
  10. Ear infection

60+:

  1. Fall
  2. Oedema (fluid collection in tissue)
  3. Dry eye (lack of adequate tears)
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Menstrual disorder (disease of menstrual cycle)
  6. Neck pain
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Productive cough
  9. Respiratory tract congestion (blockage on respiratory system)
  10. Rhinorrhoea (watery mucus discharge from the nose)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 27 people, 33.75%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 22 people, 27.50%
  3. Immunodeficiency Common Variable: 15 people, 18.75%
  4. Immunodeficiency: 11 people, 13.75%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 12.50%
  6. Immune System Disorder: 6 people, 7.50%
  7. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose): 4 people, 5.00%
  8. Drowsiness: 4 people, 5.00%
  9. Cystic Fibrosis (disease of the secretary glands): 4 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sumatriptan succinate and Turmeric?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sumatriptan succinate and Turmeric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sumatriptan succinate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Turmeric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sumatriptan succinate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Turmeric and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sumatriptan succinate and turmeric (the active ingredients of Sumatriptan succinate and Turmeric, respectively), and Sumatriptan succinate and Turmeric (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: